SCHEMBL101667

SCHEMBL101667

CNC(=O)OC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11786076 0.83
SCHEMBL11145930 0.81
SCHEMBL14084915 0.77
SCHEMBL2337430 0.77 ALDH1A1 (0.33)
SCHEMBL8511721 0.77
SCHEMBL28350080 0.75
Bromide SCHEMBL7075724 0.75 CHRM2 (0.32)
SCHEMBL18414048 0.73
SCHEMBL13316206 0.73 CHRNB2 (0.39)
SCHEMBL15362873 0.73 ALDH1A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1067 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8980319-B2 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans MALLINCKRODT LLC (US) 2015-03-17 US claimed
US-20140086987-A1 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans MALLINCKRODT LLC (US) 2014-03-27 US claimed
US-20140044786-A1 ONCE-WEEKLY ORAL ADMINISTRATION OF ARIPIPRAZOLE ZYSIS LIMITED (GB) 2014-02-13 US claimed
US-8597681-B2 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans MALLINCKRODT LLC (US) 2013-12-03 US claimed
WO-2008027442-A2 ABUSE DETERRENT ORAL PHARMACEUTICAL FORMULATIONS OF OPIOID AGONISTS AND METHOD OF USE THERAQUEST BIOSCIENCES, LLC (US) 2008-03-06 WO claimed
WO-2008021394-A2 PHARMACEUTICAL FORMULATIONS OF CANNABINOIDS AND METHOD OF USE THERAQUEST BIOSCIENCES, LLC (US) 2008-02-21 WO claimed
WO-2006002031-A1 SUSTAINED RELEASE DOSAGE FORMS ANDRX CORPORATION (US) 2006-01-05 WO claimed
US-20050276849-A1 Sustained release dosage forms ANDRX CORPORATION 2005-12-15 US claimed
WO-2004098562-A2 CONTROLLED RELEASE SOLID DOSAGE NIFEDIPINE FORMULATIONS NOVEON IP HOLDINGS CORP. (US) 2004-11-18 WO claimed
US-20040219210-A1 Controlled release solid dosage nifedipine formulations LUBRIZOL ADVANCED MATERIALS, INC. 2004-11-04 US claimed
US-5840329-A GROUPS OF PARTICLES HAVING DISTINCT PATTERN OF DRUG RELEASE BASED ON COMBINATION OF CONTROLLED RELEASE LAYERS, SWELLING AGENTS AND COATINGS; CONTROLLED RELEASE LAYER OF SLIGHTLY CROSSLINKED POLYACRYLIC ACID AND WATER SOLUBLE POLYMER BIOADVANCES LLC (US) 1998-11-24 US claimed
WO-1998051287-A1 PULSATILE DRUG DELIVERY SYSTEM BAI JANE PEI FAN (US) 1998-11-19 WO claimed
US-4116241-A FOR CONTROLLED ORAL ADMINISTRATION OF DRUG ALZA CORPORATION (US) 1978-09-26 US claimed
US-20240156811-A1 COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-05-16 US disclosed
CN-112469402-B Orally administrable and sustained release pharmaceutical dosage forms 拜耳公司 2024-05-14 CN disclosed
CN-108836948-B Product capable of realizing controllable release of nutrients by coating technology 宁波西敦医药包衣科技有限公司 2024-04-12 CN disclosed
US-4077407-A POLYSACCHARIDES ALZA CORPORATION (US) 1978-03-07 US disclosed
US-4058122-A Osmotic system with laminated wall formed of different materials ALZA CORPORATION (US) 1977-11-15 US disclosed
US-4014334-A Laminated osmotic system for dispensing beneficial agent ALZA CORPORATION (US) 1977-03-29 US disclosed
US-4008719-A Osmotic system having laminar arrangement for programming delivery of active agent ALZA CORPORATION (US) 1977-02-22 US disclosed